Mon, Jan 26, 2015, 3:46 PM EST - U.S. Markets close in 14 mins.


% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • garysnoop1 garysnoop1 May 23, 2014 5:21 PM Flag

    Insite into Market plan a few min.ago..

    Shares of Inovio Pharmaceuticals Inc(NYSEMKT:INO) are down around 6% this morning following an announcement that the company plans to initiate a 1 for 4 reverse split. According to the press release, the move was approved by both a majority of shareholders and Inovio’s Board, with an effective date to be announced at a later time.

    What’s important to understand is that this split is being announced only a few weeks ahead of the planned top line data readout for VGX-3100, Inovio’s experimental cervical cancer vaccine. Logistically, a split and a higher share price would probably do wonders in regards to institutional investment for this small-cap biotech, if the top line data are positive. Presently, institutions hold only 15% of Inovio’s outstanding shares, which has probably played a big role in the tremendous volatility in the company’s share price over the last year.

    On the flip side, a negative result for VGX-3100 would give the company room to raise funds for additional trials, without having to worry about potential delisting issues. In short, this is a smart move for the company, but its long-term consequences for shareholders won’t be known until VGX-3100′s data hit the Street.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
8.735+0.125(+1.45%)3:46 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.